Related Experiment Video
Updated: Jan 29, 2026

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices
Published on: August 1, 2025
Carvedilol vs endoscopic band ligation for the prevention of variceal bleeding: a meta-analysis
Shan Tian1, Ruixue Li2, Yingyun Guo1
1Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China, dongweiguo@whu.edu.cn.
Insights
Carvedilol and endoscopic band ligation (EBL) show similar effectiveness in preventing variceal bleeding for patients with esophageal varices. Further large-scale trials are needed for definitive conclusions on these prophylactic treatments.
Area of Science:
- Gastroenterology and Hepatology
- Clinical Pharmacology
- Interventional Endoscopy
Background:
- Variceal hemorrhage is a critical determinant of mortality in portal hypertension.
- Current guidelines advocate for endoscopic band ligation (EBL) or carvedilol for variceal bleeding prophylaxis.
- Existing clinical trials comparing carvedilol and EBL have produced conflicting outcomes.
Purpose of the Study:
- To conduct a meta-analysis of randomized controlled trials (RCTs).
- To evaluate the comparative benefits and harms of carvedilol versus EBL for preventing variceal bleeding.
- To synthesize evidence on efficacy and safety for patients with esophageal varices.
Main Methods:
- Systematic literature search of major databases (PubMed, Embase, Medline, Cochrane Library) up to August 2018.
- Inclusion of RCTs comparing carvedilol and EBL for variceal bleeding prophylaxis.
- Meta-analysis of key outcomes: variceal bleeding, all-cause mortality, bleeding-related deaths, and adverse events.
Main Results:
- Seven RCTs involving 703 patients were analyzed (359 carvedilol, 354 EBL).
- No significant difference was found in variceal bleeding rates between carvedilol and EBL (RR=0.86, 95% CI=0.60-1.23).
- Similar outcomes were observed for all-cause deaths, bleeding-related deaths, and adverse events, with no statistically significant differences.
Conclusions:
- Carvedilol and EBL demonstrate comparable efficacy in the prophylaxis of variceal bleeding in patients with esophageal varices.
- The current meta-analysis indicates no significant advantage of one treatment over the other regarding bleeding prevention or mortality.
- Larger-scale, high-quality clinical trials are necessary to establish a definitive conclusion and guide clinical practice.
Objective:
Variceal hemorrhage is the primary driver of mortality in patients with portal hypertension. Recent guidelines recommended that patients with esophageal varices should receive endoscopic band ligation (EBL) or carvedilol as prophylaxis of variceal bleeding. Several clinical trials have compared carvedilol use with EBL intervention, yielding controversial results. The present study aimed to perform a meta-analysis of randomized controlled trials (RCTs) evaluating the benefits and harms of carvedilol vs EBL for the prevention of variceal bleeding.
Methods:
Studies were searched on Pubmed, Embase, Medline, and Cochrane library databases up to August 2018. Main outcomes in selected studies (variceal bleeding, all-cause deaths, bleeding-related deaths, and adverse events) were pooled into a meta-analysis.
Results:
Seven RCTs were identified in this meta-analysis, including a total of 703 patients. A total of 359 patients were randomized to carvedilol group and 354 were randomized to EBL group. No significant difference in variceal bleeding was observed between carvedilol use and EBL groups (relative ratio [RR] =0.86, 95% CI =0.60-1.23, I 2=11%), without publication bias. No significant difference was found neither for all-cause deaths (RR =0.82, 95% CI =0.44-1.53, I 2=66%) nor for bleeding-related deaths (RR =0.85, 95% CI =0.39-1.87, I 2=42%) in four included studies. Moreover, no reduced trend was observed toward adverse events in carvedilol group compared with that in EBL group (RR =1.32, 95% CI =0.75-2.31, I 2=81%).
Conclusion:
There is no significant difference between carvedilol use and EBL intervention for the prophylaxis of variceal bleeding in patient with esophageal varices. Large-scale clinical trials are further needed to make a confirmed conclusion.
More Related Videos
Related Concept Videos
Band Theory
The energy difference between these bands is known as the band gap.
Conductor, Semiconductor,...
Esophageal Varices-I: Introduction
Bleeding in Fresh Concrete
Bleeding can cause several issues in the concrete structure. Sometimes, the rising water gets trapped beneath large aggregate...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Energy Bands in Solids
Band Formation:
When atoms are brought close together, as in a solid, these discrete energy levels begin to split due to the overlap of electron orbitals from adjacent atoms. This split occurs because of the Pauli exclusion principle, which states...
Directing Effect of Substituents: meta-Directing Groups

